Eugenia Di Loreto

Dr. Eugenia Di Loreto


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2022 in Cells
Verified
Journal Article
Open access
PDF file
Elham SajjadiElham Sajjadi
Elham Sajjadi
Konstantinos VenetisKonstantinos Venetis
Konstantinos Venetis
Marianna NoaleMarianna Noale
Marianna Noale
HAHatem A. Azim
Hatem A. Azim
CBConcetta Blundo
Concetta Blundo
EGElena Guerini-Rocco
Elena Guerini-Rocco
Breast cancer during pregnancy (PrBC) is a rare tumor with only a little information on its immune landscape. Here, we sought to characterize the cellular composition of the tumor microenvironment (TME) of PrBC and identify its differences from early-onset breast cancer (EOBC) in non-pregnant women. A total of 83 PrBC and 89 EOBC were selected from our Institutional registry and subjected to tumor-infiltrating lymphocytes (TILs) profiling and immunohistochemistry for CD4, CD8, forkhead box P3 (FOXP3), and programmed death-ligand 1 (PD-L1) (clone 22C3). A significantly lower frequency of hormone receptor (HR)-positive tumors was observed in PrBC. The prevalence of low/null PD-L1 and CD8+TILs was higher in PrBC than in the controls, specifically in HR+/HER2– breast cancers. PrBC had a significantly higher risk of relapse and disease-related death, compared to EOBC. The presence of TILs and each TIL subpopulation were significantly associated with disease relapse. Moreover, the death rate was higher in PrBC with CD8+ TILs. The TME of PrBC is characterized by specific patterns of TIL subpopulations with significant biological and prognostic roles. Routine assessment of TILs and TILs subtyping in these patients would be a valid addition to the pathology report that might help identify clinically relevant subsets of women with PrBC.

24 December 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
EMErmelinda Monti
Ermelinda Monti
GLGiada Libutti
Giada Libutti
ELEugenia Di Loreto
Eugenia Di Loreto
VBVeronica Boero
Veronica Boero
GBGiussy Barbara
Giussy Barbara
Fabio ParazziniFabio Parazzini
Fabio Parazzini

26 November 2020
Verified
Conference Paper
Closed access
ELEugenia Di Loreto
Eugenia Di Loreto
Fedro Alessandro Alessandro PeccatoriFedro Alessandro Alessandro Peccatori
Fedro Alessandro Alessandro Peccatori
GSGiovanna Scarfone
Giovanna Scarfone
AFAlessandra Familiari¹
Alessandra Familiari¹
VAVeronica Accurti
Veronica Accurti
TBTiziana Boggini
Tiziana Boggini
Introduction The maternal diagnosis of cancer complicates approximately 0,1% of all pregnancies. The most frequently diagnosed malignancies are b |